Population health and the health system: A comparative analysis of avoidable mortality in three nations and their world cities

European Journal of Public Health

Volumn 18, Issue 2, 2008, Pages 166-172

  Weisz, Daniel ^a   Gusmano, Michael K ^a,b   Rodwin, Victor G ^a,c   Neuberg, Leland G ^d  

^a International Longevity Center   (United States)

^b Columbia University ^*

^c NEW YORK UNIVERSITY   (United States)

^d BOSTON UNIVERSITY   (United States)

Author keywords

Avoidable mortality; Health system; Income

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; COMPARATIVE STUDY; DEVELOPED COUNTRY; FRANCE; HEALTH CARE ACCESS; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; INCOME; MORTALITY; PRIORITY JOURNAL; REGRESSION ANALYSIS; UNITED KINGDOM; UNITED STATES; URBAN POPULATION;

CAUSE OF DEATH; FEMALE; HEALTH SERVICES ACCESSIBILITY; HEALTH STATUS DISPARITIES; HUMANS; INCOME; LONDON; MORTALITY; NEW YORK CITY; PARIS; REGISTRIES; RESIDENCE CHARACTERISTICS; SOCIOECONOMIC FACTORS; URBAN HEALTH SERVICES; URBAN POPULATION; WALES;

EID: 40849095965     PISSN: 11011262     EISSN: 1464360X     Source Type: Journal    
DOI: 10.1093/eurpub/ckm084     Document Type: Article

References (42)

1. OECD Health Data, 2005.
2. Banks J, Marmot M, Oldfield Z, Smith J. Disease and disadvantage in the United States and England. JAMA 2006;295:2037-45.
3. World Health Organization. The World Health Report 2000 - Health Systems: Improving Performance. Last accessed 15 May 2006 at http://www.who.int/whr/2000/en/.
4. Rutstein DD, Berenberg W, Chalmers TC, et al. Measuring the quality of health care. N Engl J Med 1976;294:582-8.
5. Holland W, editor. European community atlas of avoidable death 1985-89, Oxford: Oxford University Press, 1997.
6. Tobias M, Jackson G. Avoidable mortality in New Zealand, 1981-97. Aust NZ J Public Health 2001;25:12-20.
7. Lefèvre H, Jougla E, Pavillon G, Le Toulle A. Disparitiès de mortalité 〈〈prématuré〉〉 selon le sexe et causes de décès 〈〈évitables〉〉. Rev Epidemiol Sainte Publique 2004;52:317-28.
8. Rodwin VR, Neuberg L. Infant mortality and income in four world cities: New York, London, Paris and Tokyo. Am J Public Health 2005;95:86-90.
9. Rodwin VR, Gusmano MK. The World Cities Project: rationale and design for comparison of megacity health systems. J Urban Health 2002;79:445-63.
10. Rodwin VR, Gusmano MK, Montero G. Viellir dans quatre mégapoles: New York, Londres, Paris Tokyo. Drees Études et Résultats 2003; No.260, Septembre 2003.
11. Weisz D, Gusmano MK, Rodwin VR. Gender and the treatment of heart disease in the United States, France and England: a comparative population-based view of a clinical phenomenon. Gend Med 2004;1:29-40.
12. Rodwin VR, Gusmano MK, editors. How can we compare New York, London, Paris and Tokyo? Defining spatial units of analysis. In: Growing Older in World Cities. Ch.2 Nashville: Vanderbilt University Press. 2006: 17-25.
13. Gusmano MK, Rodwin VR, Weisz D. A new way to compare health systems: avoidable hospital conditions in Manhattan and Paris. Health Aff 2006;25:510-20.
14. Gusmano MK, Rodwin VR, Weisz D, Das D. A new approach to the comparitive analysis of health systems: invasive treatment for heart disease in the US, France and their two world cities. Health Econ, Policy and Law 2007;2:73-92.
15. Berry B. Central Place Studies. Philadelphia: Regional Science Research Institute, 1961.
16. King LJ. Central Place Theory. Beverly Hills, CA: Sage, 1984.
17. The derivation of the deprivation index is available at: http://www.communities.gov.uk/pub/453/ Methodologyforanindexofmultipledeprivationreportforformalconsultation PDF251Kb_id128453.pdf. Last accessed 15 February 2007.
18. McKeown T. The role of medicine: dream, mirage or nemesis? Oxford: Blackwell, 1979.
19. Cochrane AL, St Leger AS, Moore F. Health service "input" and mortality "output" in developed countries. J Epidemiol Commun H 1978;32:200-205.
20. McKinley JB, McKinley SM. The questionable contribution of medical measures to the decline of mortality in the United States in the twentieth century. Milbank Mem Fund Quart 1977;55:405-28.
21. Illich I. Limits to medicine. London: Marion Boyars, 1976.
22. Fogel RW. The extension of life in the twentieth century and its implications for social policy in the twenty-first century. Population and Development Rev 2000;26:291-317.
23. Wilkinson R, Marmot M. Social determinants of health: the solid facts, 2nd edn. Denmark: The World Health Organization, 2003. Last accessed 16 November 2006 at http://www.euro.who.int/document/e81384.pdf.
24. Mackenbach JP. The contribution of medical care to mortality decline: McKeown revisited. J Clin Epidmiol 1996;49:1207-13.
25. Unal B, Critchley JA, Capewell S. Explaining the decline in coronary heart disease mortality in England and Wales between 1981 and 2000. Circulation 2004;109:1101-7.
26. Nolte E, McKee M. Does health care save lives? Avoidable mortality revisited. London: Nuffield Trust, 2004.
27. Treurniet HF, Boshuizen HC, Harteloh PPM. Avoidable mortality in Europe (1980-1997): a comparison of trends. J Epidemiol Commun H 2004;58:290-5.
28. Mackenbach JP, Looman CWN, Kunst AL, et al. Post-1950 mortality trends and medical care: gains in life expectancy due to declines in mortality from conditions amenable to medical intervention in the Netherlands. Soc Sci Med 1998;27:889-94.
29. Charlton JRH, Hartley RM, Silver R, Holland WW. Geographical variation in mortality from conditions amenable to medical intervention in England and Wales. Lancet 1986;1:199-202.
30. Nolte E, McKee M. Measuring the health of nations: analysis of mortality amenable to health care. Br Med J 2003;327:1129-33.
31. Hunink MGM, Goldman I, Tosteson ANA, et al. The recent decline in mortality from coronary heart disease 1980-1990. JAMA 1997;277:535-42.
32. Capewell S, Morrison CE, McMurrey JJ. Contribution of modern cardiovascular treatment and risk factor changes to the decline in coronary heart disease mortality in Scotland between 1975 and1994. Heart 1999;81:380-6.
33. Capewell S, Beaglehole R, Seddon M, McMurrey JJ. Explanation for the decline in coronary heart disease mortality in Auckland, New Zealand between 1982 and 1993. Circulation 2000;102:1511-6.
34. Klein RJ, Schoenborn CA. Age adjustment using the 2000 projected U.S. population. Healthy People 2010 Statistical Notes, No. 20. January 2001.
35. Treurniet HF, Looman CW, van der Maas PJ, Mackenbach JP. Variations in 'avoidable' mortality: a reflection of variations in incidence? Int J Epidemiol 1999;28:225-32.
36. Sandman D, Schoen C, Des Roches C. The Commonwealth Fund Survey of Health Care in New York City. The Commonwealth Fund, February 1998.
37. Evandrou M. Inequalities amongst older people in London: the challenge of diversity. In: Rodwin VR, Gusmano MK, editors. Growing older in world cities: New York, London, Paris and Tokyo, Ch. 9, Nashville: Vanderbilt University Press, 2006:173-98 .
38. Cavelaars AE, Kunst AE, Mackenbach JP. Socioeconomic differences in risk factors for morbidity and mortality in the European community: an international comparison. J Health Psychol 1997;2:353-72.
39. Lynch JW, Kaplan GA, Salonen JT. Why do poor people behave poorly? Variation in adult health behaviours and psychosocial characteristics by stage of the socioeconomic lifecourse. Soc Sci Med 1997;44:810-9.
40. Tobier E. Growing older in the city that never sleeps: aging in New York. In: Rodwin VR, Gusmano MK, editors. Growing older in world cities: New York, London, Paris and Tokyo, Ch. 3, Nashville: Vanderbilt University Press, 2006:27-55.
41. Marmot MG, Smith GD, Stansfield S. Health inequalities among British civil servants: the Whitehall II study. Lancet 1991;337:1387-93.
42. Pappas G, Queen S, Hadden W. The increasing disparity in mortality between socioeconomic groups in the United States, 1960 and 1986. N Engl J Med 993;329:1032-109.